Clinical Trial Finder

Be a part of the movement transforming the future of cystic fibrosis treatment.

Clinical trials are listed below.

  • BehavioralEnrolling Location: USA

    Phase 4 study of adherence to lumacaftor/ivacaftor in people with CF , protocol number Vertex VX-809-114

    This study is taking place at multiple care centres across the US. It will look at the impact of using a smart device that monitors medication use on adherence to lumacaftor/ivacaftor.

    • Age:

      16 Years and Older

    • Mutation(s):

      Two Copies F508del

    • FEV1% Predicted:

      40% or greater

    • Number of Visits:

      7

    • Length of Participation:

      48 weeks

    Contact us about this clinical Trial >
  • Restore CFTR FunctionEnrolling Location: Multiple US sites

    Phase 2 study of CTP-656 in aduts with CF who are currently taking ivacaftor (Kalydeco) , protocol number CP656.2001 ClinicalTrials.gov Identifier: NCT02971839

    This study will evaluate the safety and effectiveness of the drug, CTP-656 in adults with Cystic Fibrosis who have a gating mutation and are currently taking ivacaftor (KALYDECO)

    • Age:

      18 years and older

    • Mutation(s):

      One copy F508del or no copies F508del

    • FEV1% Predicted:

      60-90%

    • Number of Visits:

      6

    • Length of Participation:

      7 weeks

    Contact us about this clinical Trial >
  • Displaying results 141-142 (of 142)
     |<  <  6 - 7 - 8 - 9 - 10 - 11 - 12 - 13 - 14 - 15 >  >|